NASDAQ · BIB
ProShares Ultra Nasdaq Biotechnology
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
Loading market information…
AMEX · DXD · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ProShares UltraShort Dow30’s quoted price sits in the lower half of its reported 52-week range, 24.13% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
ProShares UltraShort Dow30’s forward annual dividend is $0.61 per share, paid quarterly. The forward yield is 3.48% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
DXD is designed to deliver -2x daily performance of the 30 US large-caps in the DJIA, weighted by price. As with any fund tracking the popular but dated DJIA, it's important to remember that it's not tracking a particularly robust representation of the larger US equity market. This is inverted, geared exposure to an index with arbitrary sector biases and antiquated weighting. Anyone holding DXD for longer than a day will be exposed to the path dependency. This dynamic is especially acute in funds that overlay leverage on inverse exposure as DXD does. Longer term investors must manage their exposure on a daily basis or use it as it was intended to be used: as a short-term trading tool. The expense ratio for DXD matters less than the total all in trading costs.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 10:50 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$120.53+$0.00 (0.0%)
ProShares Ultra Nasdaq Biotechnology’s quoted price sits in the upper half of its reported 52-week range, 4.64% below the high.
$27.48-$0.62 (-2.21%)
First Trust New Constructs Core Earnings Leaders ETF’s quoted price sits in the upper half of its reported 52-week range, 3.75% below the high.
$50.66-$0.83 (-1.61%)
ProShares - Ultra S&P 500 Equal Weight’s quoted price sits in the upper half of its reported 52-week range, 5.43% below the high.
$79.56-$13.85 (-14.83%)
Direxion Daily S&P 500 High Beta Bull 3X ETF’s quoted price sits in the lower half of its reported 52-week range, 42.39% below the high.
$35.12-$0.34 (-0.95%)
AllianzIM U.S. Equity 6 Month Buffer10 Feb/Aug ETF’s quoted price sits in the upper half of its reported 52-week range, 1.35% below the high.
$49.45+$0.09 (+0.18%)
BondBloxx BBB Rated 5-10 Year Corporate Bond ETF’s quoted price sits in the lower half of its reported 52-week range, 6.24% below the high.
$14.70+$0.09 (+0.62%)
AdvisorShares Active Bear ETF’s quoted price sits in the lower half of its reported 52-week range, 20.33% below the high.
$21.53+$0.31 (+1.46%)
Direxion Daily 7-10 Year Treasury Bull 3X ETF’s quoted price sits in the lower half of its reported 52-week range, 19.54% below the high.
